Bone health and glucocorticoid-containing lymphoma therapy - a review of risk factors and preventative measures

Autor: Toby A. Eyre, Paw Jensen, Stephen Booth, Tarec Christoffer El‐Galaly

Publikováno v: Eyre, T A, Jensen, P, Booth, S & El-Galaly, T C 2022, ' Bone health and glucocorticoid-containing lymphoma therapy-a review of risk factors and preventative measures ', British Journal of Haematology, vol. 198, no. 3, pp. 431-442 . https://doi.org/10.1111/bjh.18104

With survival outcomes ever improving for patients with a wide range of lymphoma histologies, the focus on reducing long-term complications of therapy has increased. Recently published, complimentary population and retrospective series have highlight

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d169994ce1ba8bd861d4a7a9a2c26a91
https://vbn.aau.dk/da/publications/d37406f2-405b-41cd-a410-a52ee1afd182

Quercetin as a Novel Therapeutic Approach for Lymphoma

Autor: William C. Cho, Vahideh Tarhriz, Kamran Hosseini, Parina Asgharian, Javad Sharifi-Rad, Saiedeh Razi Soofiyani, Haleh Forouhandeh, Željko Reiner, Tohid Ghasemnejad

Publikováno v: Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)

Lymphoma is a name for malignant diseases of the lymphatic system including Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. Although several approaches are used for the treatment of these diseases, some of them are not successful and have serious

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2b91e03dab772a4ce7e253b92128d3c

Effects of live music during chemotherapy in lymphoma patients:a randomized, controlled, multi-center trial

Autor: Margrethe Langer Bro, Peter Vuust, Elisabeth Wreford Andersen, Christoffer Johansen, Peter de Nully Brown, Jeppe Gram, Niels Abildgaard, Bodil Himmelstrup, Torben Mourits-Andersen, Francesco d'Amore, Lisbeth Enggaard

Publikováno v: Bro, M L, Johansen, C, Vuust, P, Enggaard, L, Himmelstrup, B, Mourits-Andersen, T, Brown, P, d'Amore, F, Andersen, E A W, Abildgaard, N & Gram, J 2019, ' Effects of live music during chemotherapy in lymphoma patients : a randomized, controlled, multi-center trial ', Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 27, no. 10, pp. 3887-3896 . https://doi.org/10.1007/s00520-019-04666-8
Bro, M L, Johansen, C, Vuust, P, Enggaard, L, Himmelstrup, B, Mourits-Andersen, T, Brown, P, d'Amore, F, Andersen, E A W, Abildgaard, N & Gram, J 2019, ' Effects of live music during chemotherapy in lymphoma patients : a randomized, controlled, multi-center trial ', Supportive Care in Cancer, vol. 27, no. 10, pp. 3887-3896 . https://doi.org/10.1007/s00520-019-04666-8
Bro, M L, Johansen, C, Vuust, P, Enggaard, L, Himmelstrup, B, Mourits-Andersen, T, Brown, P, d’Amore, F, Andersen, E A W, Abildgaard, N & Gram, J 2019, ' Effects of live music during chemotherapy in lymphoma patients : a randomized, controlled, multi-center trial ', Supportive Care in Cancer, vol. 27, no. 10, pp. 3887-3896 . https://doi.org/10.1007/s00520-019-04666-8

PURPOSE: Chemotherapy is associated with both somatic and psychological side effects. Music might ease these problems. Several randomized controlled trials have investigated the effect of music, but the results are inconclusive. We aimed to examine w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::335bf9140fa56843ffd8f0f638d41774
https://pure.au.dk/portal/da/publications/effects-of-live-music-during-chemotherapy-in-lymphoma-patients(27116482-7307-4a5b-b0dd-02be10a979be).html

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Autor: Chalandon, Yves, Thomas, Xavier, Hayette, Sandrine, Cayuela, Jean-Michel, Abbal, Claire, Huguet, Françoise, Raffoux, Emmanuel, Leguay, Thibaut, Rousselot, Philippe, Lepretre, Stéphane, Escoffre-Barbe, Martine, Maury, Sébastien, Berthon, Céline, Tavernier, Emmanuelle, Lambert, Jean-François, Lafage-Pochitaloff, Marina, Lhéritier, Véronique, Chevret, Sylvie, Ifrah, Norbert, Dombret, Hervé, Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)

Publikováno v: Blood, Vol. 125, No 24 (2015) pp. 3711-3719

In this study, we randomly compared high doses of the tyrosine kinase inhibitor imatinib combined with reduced-intensity chemotherapy (arm A) to standard imatinib/hyperCVAD (cyclophosphamide/vincristine/doxorubicin/dexamethasone) therapy (arm B) in 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ff7b8fa7c747ce8aaa642d7f259a20
https://doi.org/10.1182/blood-2015-02-627935

Allergic Reactions to E. coli L-Asparaginase Do Not Affect Outcome in Childhood B-precursor Acute Lymphoblastic Leukemia

Autor: Pierre Wacker, Jeanette Pullen, Jonathan J. Shuster, Michael E. Harris, Vita J. Land, Joanne Kurtzberg, Bruce M. Camitta

Publikováno v: Journal of Pediatric Hematology / Oncology, Vol. 29, No 9 (2007) pp. 627-32

We describe the outcome of children with B-precursor acute lymphoblastic leukemia registered on Pediatric Oncology Group 8602 who switched to Erwinia asparaginase (ASP) due to an allergy to the Escherichia coli product. Between February 1986 and Janu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::661b1a69925c94903943ce8a05fc55a9
https://doi.org/10.1097/mph.0b013e3181483df1